AT1 FY21 - General Discussion + FA, page-712

Atomo Diagnostics managing director John Kelly said news of Ellume’s successes “helps the sector in general and provides more confidence”.Atomo generates the majority of its business offshore, with a flagship product which is a self-HIV test, as well as TGA-approved COVID-19 tests. Mr Kelly said while there was traction growing in the diagnostics space, home-grown businesses had to be well-funded and globally-focused to succeed.“You’ve got to be well capitalised and the Australian market is limited by its size. If you want to get beyond a certain size, you have to head overseas.”Mr Lanyon agreed, saying Ellume's success came after securing significant funding both overseas and in Australia, where the Queensland government committed $50 million to support the manufacturing effort."It takes a lot of investment to do this - and the more capital available, the better." From an article Dec 17th